Since this study was designed, we have found that GM-CSF decreases both CD4+ and CD8+ responses to melanoma vaccines in incomplete Freund’s Adjuvant [16]; thus, we anticipate that vaccination with melanoma helper peptides without GM-CSF or in different adjuvant systems may be even more effective at inducing high magnitude Th1-dominant immune responses. The gene discussed is CD4; the disease is melanoma.